Experimental Lilly med shrank nearly 70% of tumors in lung cancer trial

The drug LOXO-292 was acquired by the drugmaker in the beginning of the year when it took over Loxo Oncology for $8 billion
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news